Alevin Therapeutics

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Galecto

This biotechnology company develops small molecule therapeutics targeting galectin-3 and LOXL2 to treat patients with fibrosis, inflammation and cancer.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Origo Biopharma

This clinical-stage biotechnology company develops small molecule therapies targeting the transforming growth factor beta pathway to treat fibrosis and cancer in healthcare patients.

MDI Therapeutics

This pharmaceutical company develops serpin-based therapies to treat patients with chronic fibrosis, inflammatory diseases and fibroproliferative disorders.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.